rg 14893 has been researched along with Inflammation in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chambers, PA; Daines, RA; Foley, JJ; Griswold, DE; Jakas, DR; Martin, LD; Pendrak, I; Sarau, HM; Schmidt, DB; Tzimas, MN | 1 |
1 other study(ies) available for rg 14893 and Inflammation
Article | Year |
---|---|
(E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid: a novel high-affinity leukotriene B4 receptor antagonist.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; Calcium; Humans; Inflammation; Leukotriene B4; Mice; Molecular Structure; Neutrophils; Pyridines; Receptors, Leukotriene B4 | 1993 |